WallStreetZenWallStreetZen

NASDAQ: CYCN
Cyclerion Therapeutics Inc Earnings & Revenue

CYCN past revenue growth

How has CYCN's revenue growth performed historically?
Company
-100%
Industry
83.05%
Market
15.22%
CYCN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CYCN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CYCN earnings and revenue history

Current Revenue
$0.0
Current Earnings
$149.0k
Current Profit Margin
0%

CYCN Return on Equity

Current Company
1.5%
Current Industry
16.7%
Current Market
28.2%
CYCN's Return on Equity (1.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CYCN announces earnings.

CYCN Return on Assets

Current Company
1.2%
Current Industry
3.2%
CYCN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CYCN Return on Capital Employed

Current Company
-1.99%
Current Industry
-43.6%
CYCN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CYCN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CYCN$0.00-$197.00k$149.00k-100.00%N/A
TRVN$3.14M-$35.78M-$40.15M-11.35%N/A
TENX$0.00-$10.07M-$10.10MN/AN/A
PYPD$0.00-$21.05M-$23.87MN/A+28.76%
LGVN$978.00k-$19.86M-$21.62M-91.75%N/A

Cyclerion Therapeutics Earnings & Revenue FAQ

What were CYCN's earnings last quarter?

On Invalid Date, Cyclerion Therapeutics (NASDAQ: CYCN) reported Q1 2024 earnings per share (EPS) of -$0.62, up 80.63% year over year. Total Cyclerion Therapeutics earnings for the quarter were -$1.54 million. In the same quarter last year, Cyclerion Therapeutics's earnings per share (EPS) was -$3.20.

If you're new to stock investing, here's how to buy Cyclerion Therapeutics stock.

What was CYCN's earnings growth in the past year?

As of Q2 2024, Cyclerion Therapeutics's earnings has grown year over year. Cyclerion Therapeutics's earnings in the past year totalled $149.00 thousand.

What was CYCN's revenue last quarter?

On Invalid Date, Cyclerion Therapeutics (NASDAQ: CYCN) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cyclerion Therapeutics's revenue was $0.00.

What was CYCN's revenue growth in the past year?

As of Q2 2024, Cyclerion Therapeutics's revenue has grown -100% year over year. This is 183.05 percentage points lower than the US Biotechnology industry revenue growth rate of 83.05%. Cyclerion Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.